Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Combo Product Excitement: Large Players On Look-Out For Early-Stage Deals

This article was originally published in The Gray Sheet

Executive Summary

Heightened corporate interest in innovative drug-delivery technologies offers greater opportunities for small device firms to attract larger company investment, venture capitalists say

You may also be interested in...



ImaRx’ Combo Treatment For Stroke To Wrap Up Phase I/II Trial By Mid-2008

ImaRx is on track to complete enrollment in a Phase I/II dose escalation study by mid-2008 for its combo product SonoLysis, which uses ultrasound and microbubbles to treat acute ischemic stroke

ImaRx’ Combo Treatment For Stroke To Wrap Up Phase I/II Trial By Mid-2008

ImaRx is on track to complete enrollment in a Phase I/II dose escalation study by mid-2008 for its combo product SonoLysis, which uses ultrasound and microbubbles to treat acute ischemic stroke

Boston Scientific COO Praises FDA Combo Efforts, Warns of Grueling Process

FDA's combination products approval process is effective at offsetting some challenges to developing and marketing drug-device pairings, according to Boston Scientific Chief Operating Officer Paul LaViolette

Related Content

UsernamePublicRestriction

Register

OM004634

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel